@article{dupuis:hal-01162051,
TITLE = {Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access program.},
AUTHOR = {Dupuis, J and Brice, P and Fran{\c c}ois, S and Ysebaert, Loic and de Guibert, S and Levy, V and Lepr{\^e}tre, S and Choquet, S and Dilhuydy, M S and Fornecker, L and Morel, V and Tempescul, A},
URL = {https://hal.science/hal-01162051},
JOURNAL = {Clinical Lymphoma, Myeloma \& Leukemia},
PUBLISHER = {Elsevier},
VOLUME = {15},
NUMBER = {2},
PAGES = {e43-6},
YEAR = {2015},
MONTH = Jan, DOI = {10.1016/j.clml.2014.07.013},
KEYWORDS = {Ofatumumab ; CLL ; CD20 ; Relapsed/refractory ; Temporary use authorization},
HAL_ID = {hal-01162051},
HAL_VERSION = {v1},
}